Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

Let's Fight

March 8th 2018, 7:20pm

Podcast

Tony Beasley has spent years in the MLB as a third-base coach for the Texas Rangers. Little did he know his competitive nature and critical thinking would come in to play in his fight against stage 2 colorectal cancer. Since, Beasley has teamed up with Fight CRC as part of their One Million Strong Campaign to help others do one thing: Develop a mentality to fight.

MSI-H Status: What You Need to Know

January 30th 2018, 11:47pm

Article

CURE spoke with Scott Paulson, M.D., medical oncologist with Texas Oncology, an affiliate of The US Oncology Network, to break down exactly what MSI-H status is, and the effects it may have on certain malignancies.

Genetic Markers Can Help Predict CRC Outcomes

January 28th 2018, 1:24am

Article

The identification of microsatellite status, tumor mutational burden and protein expression in colorectal cancer (CRC) tumors may lead to better outcomes in a subgroup of patients.

Exploring Clonal Evolution in Colorectal Cancer

January 27th 2018, 7:26pm

Article

Patients with microsatellite instability-high (MSI-H) colorectal cancer may undergo a distinct pattern of clonal evolution, which in turn, would impact the use of targeted and immunologic therapies in these patients, according to study results presented at the 2018 Gastrointestinal Cancer Symposium.

Opdivo Regimens Improve Long-Term Colorectal Cancer Outcomes

January 26th 2018, 8:25pm

Article

Patients previously treated for DNA mismatch repair (MMR)-deficient/microsatellite instability-high (MSI-H) metastatic colorectal cancer may have a new effective treatment option.

One Million Strong

January 25th 2018, 9:23pm

Article

Texas Rangers third-base coach Tony Beasley teams up with Fight CRC, sharing his journey into survivorship and inspiring others in their fight against cancer.

MSI Testing Is Crucial in Colorectal Cancer

January 24th 2018, 1:27am

Video

Genetic testing – particularly for microsatellite instability (MSI) – is an important step for all patients diagnosed with colorectal cancer.

Molecular Testing Is Key in Understanding MSI-H Colorectal Cancer

January 16th 2018, 10:29pm

Article

In recent years, next-generation sequencing has allowed physicians and researchers alike to gather more genetic data for patients with gastrointestinal cancers. And while this kind of profiling continues to advance, so do treatment options for this patient population.

Examining Response Rates in MSI-H and NTRK Fusion GI Cancers

January 11th 2018, 12:29am

Video

Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.

Examining Immunotherapy's Role in Colorectal Cancer

November 27th 2017, 8:49pm

Article

“The very exciting field of checkpoint inhibitors is still evolving, and we are trying to understand where they fit in the world of CRC therapy,” said McCollum, a hematologist and medical oncologist at Texas Oncology.